Michael D Prados

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.

Susan Chang, Susan M. Chang, M. Prados, 2006, Neuro-oncology.

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.

Li Zhang, Howard Colman, Dima Suki, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural Subtype

Ivan Smirnov, Arie Perry, Mitchel S Berger, 2012, Journal of neuropathology and experimental neurology.

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

Mitchel S Berger, Raj K Puri, Susan M. Chang, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide in the treatment of recurrent malignant glioma

Susan M. Chang, M. Prados, P. Theodosopoulos, 2004, Cancer.

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Paul S Mischel, Steve Horvath, Timothy F Cloughesy, 2012, Cancer discovery.

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

Zhaoshi Jiang, Somasekar Seshagiri, Franklin Peale, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toward precision medicine in glioblastoma: the promise and the challenges.

Timothy C Ryken, Timothy F Cloughesy, Annette M Molinaro, 2015, Neuro-oncology.

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Lorenzo Trippa, Brian M Alexander, Paul S Mischel, 2015, Neuro-oncology.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.

Mitchel S Berger, Christoph Pedain, Raj K Puri, 2006, Neurosurgical focus.

Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults.

Mitchel S Berger, Susan M. Chang, M. Berger, 2005, Journal of neurosurgery.